These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2154795)

  • 1. Cyprodime analogues: synthesis and pharmacological evaluation.
    Schmidhammer H; Smith CF; Erlach D; Koch M; Krassnig R; Schwetz W; Wechner C
    Prog Clin Biol Res; 1990; 328():37-40. PubMed ID: 2154795
    [No Abstract]   [Full Text] [Related]  

  • 2. (-)-N,N'-but-2-ene-1,4-diylbimorphinans.
    Schmidhammer H; Smith CF; Dalkner E; Erlach D; Heuberger M; Rollinger JM
    Pharmazie; 1991 Feb; 46(2):101-2. PubMed ID: 1649476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and biological evaluation of 14-alkoxymorphinans, V: 6-Deoxyocyprodime, an opioid antagonist with decreased mu receptor selectivity in comparison to cyprodime.
    Schmidhammer H; Jennewein HK; Smith CF
    Arch Pharm (Weinheim); 1991 Apr; 324(4):209-11. PubMed ID: 1650547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and biological evaluation of 14-alkoxymorphinans. 3. Extensive study on cyprodime-related compounds.
    Schmidhammer H; Smith CF; Erlach D; Koch M; Krassnig R; Schwetz W; Wechner C
    J Med Chem; 1990 Apr; 33(4):1200-6. PubMed ID: 2157011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, opioid receptor binding, and functional activity of 5'-substituted 17-cyclopropylmethylpyrido[2',3':6,7]morphinans.
    Ananthan S; Kezar HS; Saini SK; Khare NK; Davis P; Dersch CM; Porreca F; Rothman RB
    Bioorg Med Chem Lett; 2003 Feb; 13(3):529-32. PubMed ID: 12565965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and biological evaluation of 14-alkoxymorphinans. 21. Novel 4-alkoxy and 14-phenylpropoxy derivatives of the mu opioid receptor antagonist cyprodime.
    Spetea M; Schüllner F; Moisa RC; Berzetei-Gurske IP; Schraml B; Dörfler C; Aceto MD; Harris LS; Coop A; Schmidhammer H
    J Med Chem; 2004 Jun; 47(12):3242-7. PubMed ID: 15163203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of the mouse vas deferens to determine mu, delta, and kappa receptor affinities of opioid antagonists.
    Cohen ML; Mendelsohn LG; Mitch CH; Zimmerman DM
    Receptor; 1994; 4(1):43-53. PubMed ID: 8038706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-protection of mu and delta opioid receptors in the mouse vas deferens.
    Sheehan MJ; Hayes AG; Tyers MB
    NIDA Res Monogr; 1986; 75():85-8. PubMed ID: 2829013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro evaluation of a novel, non-competitive opioid receptor antagonist.
    Davis P; Kramer T; Burks T
    Proc West Pharmacol Soc; 1989; 32():163-6. PubMed ID: 2550940
    [No Abstract]   [Full Text] [Related]  

  • 10. Synthesis and biological evaluation of 14-alkoxymorphinans. 2. (-)-N-(cyclopropylmethyl)-4,14-dimethoxymorphinan-6-one, a selective mu opioid receptor antagonist.
    Schmidhammer H; Burkard WP; Eggstein-Aeppli L; Smith CF
    J Med Chem; 1989 Feb; 32(2):418-21. PubMed ID: 2536439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evolution of the Dmt-Tic pharmacophore: N-terminal methylated derivatives with extraordinary delta opioid antagonist activity.
    Salvadori S; Balboni G; Guerrini R; Tomatis R; Bianchi C; Bryant SD; Cooper PS; Lazarus LH
    J Med Chem; 1997 Sep; 40(19):3100-8. PubMed ID: 9301674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and biological evaluation of 14-alkoxymorphinans. 11. 3-Hydroxycyprodime and analogues: opioid antagonist profile in comparison to cyprodime.
    Schmidhammer H; Jennewein HK; Krassnig R; Traynor JR; Patel D; Bell K; Froschauer G; Mattersberger K; Jachs-Ewinger C; Jura P
    J Med Chem; 1995 Aug; 38(16):3071-7. PubMed ID: 7636870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New delta-receptor antagonists.
    Thornber CW; Shaw JS; Miller L; Hayward CF; Morley JS; Timms D; Wilkinson A
    NIDA Res Monogr; 1986; 75():177-80. PubMed ID: 2828968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel cyclic enkephalin analogue with potent opioid antagonist activity.
    Weltrowska G; Lu Y; Lemieux C; Chung NN; Schiller PW
    Bioorg Med Chem Lett; 2004 Sep; 14(18):4731-3. PubMed ID: 15324897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delta and kappa opioid receptors in the rabbit ear artery.
    Berzetei IP; Fong A; Duckles SP
    NIDA Res Monogr; 1986; 75():105-8. PubMed ID: 2828953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RX809055AX in vivo: a long lasting opioid antagonist at mu and delta receptors.
    Lemcke PK; Ayres EA; Kramer TH; Burks TF
    Proc West Pharmacol Soc; 1989; 32():173-5. PubMed ID: 2550942
    [No Abstract]   [Full Text] [Related]  

  • 17. Opioid profiles of Cys2-containing enkephalin analogues.
    Pencheva N; Milanov P; Vezenkov L; Pajpanova T; Naydenova E
    Eur J Pharmacol; 2004 Sep; 498(1-3):249-56. PubMed ID: 15364002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and biological evaluation of 14-alkoxymorphinans. 22.(1) Influence of the 14-alkoxy group and the substitution in position 5 in 14-alkoxymorphinan-6-ones on in vitro and in vivo activities.
    Lattanzi R; Spetea M; Schüllner F; Rief SB; Krassnig R; Negri L; Schmidhammer H
    J Med Chem; 2005 May; 48(9):3372-8. PubMed ID: 15857143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and preliminary in vitro investigation of bivalent ligands containing homo- and heterodimeric pharmacophores at mu, delta, and kappa opioid receptors.
    Peng X; Knapp BI; Bidlack JM; Neumeyer JL
    J Med Chem; 2006 Jan; 49(1):256-62. PubMed ID: 16392810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Site-directed alkylation of multiple opioid receptors. II. Pharmacological selectivity.
    Goldstein A; James IF
    Mol Pharmacol; 1984 May; 25(3):343-8. PubMed ID: 6328260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.